transplantation of heart

Russell, chief of heart failure and transplantation at Johns Hopkins Hospital in Baltimore.

是位于巴尔的摩的Johns Hopkins医院的心力衰竭病及心脏移植首席医师。

Objective: To evaluate the feasibility and efficacy of via coronary transplantation of bone marrow mononuclear cells in treating ischemic heart failure.

目的：为研究自体骨髓单个核细胞经冠脉内移植治疗缺血性心力衰竭的可行性和疗效。

Methods Model of mice cervical heterotopic heart transplantation was established.

方法采用小鼠颈部心脏移植模型,随机分为3组:对照组,移植组,落新妇甙组.

The Therapy Of Transplantation OF Stem Cell Therapy Ischemic Heart Disease

干细胞移植治疗缺血性心脏病现状与进展

Cellular transplantation is being explored as a newly developed strategy for treating patients with end-stage heart disease, and bone marrow mesenchymal stem cells ( BMSCs) have been proposed as a type of ideal candidate.

细胞移植治疗是治疗心脏疾病的一种新策略。骨髓间充质干细胞（BMSCs）目前被认为是细胞移植治疗最理想的种子细胞。

Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells Transfected Ex Vivo by ANG or VEGF Gene in a Porcine Chronic Ischemic Heart Model

转染ANG及转染VEGF基因的自体骨髓间充质干细胞移植治疗慢性缺血性心脏病的实验研究

Therapeutic drug monitoring of cyclosporin-A after the first heart transplantation in GUANGXI

广西首例心脏移植术后环孢素A的药物监测

CONCLUSION Our newly established murine model of heterotopic heart transplantation is stable and reliable.

结论采用新方法可提高小鼠腹腔异位心脏移植成功率.

The recent study shows that TGF-1, can antagonize allograft rejection, and the application of TGF-P jto the allogeneic heart transplantation and pancreas islet cell transplantation model in the mice and rats can significantly prolong the allograft survival.

近、－来研究发现，TGF民能够对抗免疫排斥反应，在小鼠及大鼠同种异体心脏移植及－。胰岛细胞移植模型中应用TGF－民能够明显延长移植物存活时间。